News
Senegal and Team Europe agree to build a manufacturing plant to produce vaccines against COVID-19 and other endemic diseases
Producing COVID-19 vaccines in Africa came one step closer today after Team Europe formally agreed to support large-scale investment in vaccine production by the Institut Pasteur in Dakar, alongside other support measures. The new manufacturing plant should reduce Africa's...
News
Serum Institute partners with RDIF to make 300 mn doses of Sputnik V
Sputnik V’s production in India has received a shot in the arm as the developers of the Russian Covid-19 vaccine and Serum Institute of India (SII) announced a partnership agreement on Tuesday to manufacture more than 300 million doses,...
News
Sri Trang Group accelerates Covid inoculation program
Pressing ahead with its campaign to provide inoculation to all Southeast Asia based employees of the Sri Trang Group of Companies against Covid-19 with Sinopharm vaccine, provided by the Chulabhorn Royal Academy, Sri Trang Gloves (Thailand) PCL reached its...
Clinical Trials
Genoskin launches the ISR platform: the first human skin ex vivo platform to study injection site reactions ahead of clinical trials
Genoskin announces the launch of the ISR platform®, a new pre-clinical toolbox designed to study injection site reactions (ISR) in humans ahead of clinical trials. The company has filed intellectual property to protect its transformative platform worldwide. With the...
News
Moderna COVID-19 vaccine approved for use in Saudi Arabia
Saudi Arabia has approved the Moderna coronavirus vaccine for emergency use, making it the fourth jab to be administered in the Kingdom along with Pfizer-BioNTech, Oxford-AstraZeneca and Johnson & Johnson.
In a statement on Friday carried by the Saudi Press...
Drug Research
Novasep signs a manufacturing services agreement with Exelixis for a next-generation ADC
Novasep, a leading supplier of services and technologies for the life sciences industry, is pleased to announce the signature of a manufacturing services agreement with Exelixis, a commercially successful, oncology-focused US biotechnology company, for the cGMP clinical production of...
News
Valneva Awarded FDA Breakthrough Designation for its Single-Shot Chikungunya Vaccine Candidate
Valneva SE, a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need, announced that it has been awarded Breakthrough Therapy Designation for its single-shot chikungunya vaccine candidate, VLA1553,...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read